{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-052946","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2025-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.048235+00:00","generated_at":"2026-05-24T22:41:27.459561+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"biote Q4 2024 revenue up 9% to $49.8M; EPS falls to $0.10 from $0.18","bullets":["Q4 2024 revenue $49.8M, procedure revenue $36.6M, net income $3.5M ($0.10 EPS) vs $12.1M ($0.18 EPS) a year ago.","Full year 2024 revenue $197.2M (+6.4% YoY); net income $0.05M (vs net loss $2.8M in 2023).","Adjusted EBITDA Q4 $15.1M (30.3% margin); full year $58.2M (29.5% margin).","Gross profit margin improved to 71.8% Q4 (70.5% full year) on vertical integration of 503B facility.","Cash and cash equivalents $39.3M at year-end; fiscal 2025 outlook provided but not detailed in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-052946","json":"https://secwatch.observer/filing/0001193125-25-052946.json","markdown":"https://secwatch.observer/filing/0001193125-25-052946.md","text":"https://secwatch.observer/filing/0001193125-25-052946.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312525052946/0001193125-25-052946-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312525052946/d936042d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T22:41:27.459561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}